166 related articles for article (PubMed ID: 32814321)
1. Short-Term Intravenous Infusion of Cyclophosphamide in the Treatment of Refractory Pemphigus Vulgaris: A Retrospective Study.
Zhang W; Wei S; Peng X; Xie S; Zhang Z; Zeng K; Lai K
Dermatology; 2021; 237(2):185-190. PubMed ID: 32814321
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
[TBL] [Abstract][Full Text] [Related]
3. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
[TBL] [Abstract][Full Text] [Related]
4. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
Werth VP
Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
[TBL] [Abstract][Full Text] [Related]
5. Pulse intravenous cyclophosphamide therapy in pemphigus.
Fleischli ME; Valek RH; Pandya AG
Arch Dermatol; 1999 Jan; 135(1):57-61. PubMed ID: 9923782
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
Lever WF; Schaumburg-Lever G
Arch Dermatol; 1977 Sep; 113(9):1236-41. PubMed ID: 900969
[TBL] [Abstract][Full Text] [Related]
7. Ultra-low dose rituximab for refractory pemghigus vulgaris: a pilot study.
Russo I; Miotto S; Saponeri A; Alaibac M
Expert Opin Biol Ther; 2020 Jun; 20(6):673-678. PubMed ID: 32027810
[No Abstract] [Full Text] [Related]
8. Steroid-pulse therapy in pemphigus vulgaris long term follow-up.
Chryssomallis F; Dimitriades A; Chaidemenos GC; Panagiotides D; Karakatsanis G
Int J Dermatol; 1995 Jun; 34(6):438-42. PubMed ID: 7657447
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the role of immunoablative high-dose cyclophosphamide therapy in pemphigus vulgaris.
Nousari CH; Brodsky R; Anhalt GJ
J Am Acad Dermatol; 2003 Jul; 49(1):148-50. PubMed ID: 12833031
[No Abstract] [Full Text] [Related]
10. [A clinical analysis of 64 cases of pemphigus].
He Z; Wang B; Yu B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Apr; 20(2):144-7. PubMed ID: 11367721
[TBL] [Abstract][Full Text] [Related]
11. The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris.
Momeni AZ; Iraji F; Aminjavaheri M; Emami MR; Momeni A
J Dermatolog Treat; 2007; 18(5):275-8. PubMed ID: 17852639
[TBL] [Abstract][Full Text] [Related]
12. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.
Hayag MV; Cohen JA; Kerdel FA
J Am Acad Dermatol; 2000 Dec; 43(6):1065-9. PubMed ID: 11100024
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rituximab therapy in patients with pemphigus vulgaris: first report from Turkey.
Uzun S; Bilgiç Temel A; Akman Karakaş A; Ergün E; Özkesici B; Eskiocak AH; Erat A; Uğurlu N; Nazlım B; Koç S; Bozkurt S; Dicle Ö; Alpsoy E; Yılmaz E
Int J Dermatol; 2016 Dec; 55(12):1362-1368. PubMed ID: 27653507
[TBL] [Abstract][Full Text] [Related]
14. Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus.
Cummins DL; Mimouni D; Anhalt GJ; Nousari CH
J Am Acad Dermatol; 2003 Aug; 49(2):276-80. PubMed ID: 12894077
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission.
Russo I; De Siena FP; Saponeri A; Alaibac M
Medicine (Baltimore); 2017 Nov; 96(46):e8801. PubMed ID: 29145342
[TBL] [Abstract][Full Text] [Related]
16. Pulse therapy in pemphigus: report of 11 cases.
Fernandes NC; Menezes M
An Bras Dermatol; 2013; 88(4):672-5. PubMed ID: 24068153
[TBL] [Abstract][Full Text] [Related]
17. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
Rose E; Wever S; Zilliken D; Linse R; Haustein UF; Bröcker EB
J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814
[TBL] [Abstract][Full Text] [Related]
18. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy.
Citarrella P; Gebbia V; Di Marco P; Tambone Reyes M; Noto G; Aricò M
J Chemother; 1992 Feb; 4(1):56-8. PubMed ID: 1403072
[TBL] [Abstract][Full Text] [Related]
20. Immunological markers as predictors of developing steroid-induced diabetes mellitus in pemphigus vulgaris patients: An observational study.
Dănescu AS; Bâldea I; Leucuţa DC; Lupan I; Samaşca G; Sitaru C; Chiorean R; Baican A
Medicine (Baltimore); 2018 Apr; 97(17):e0463. PubMed ID: 29702999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
